Pediatrix Medical Group, Inc. (MD): who owns it and who trades it
As of Nov 16, 2026, MD insiders reported 3 open-market sales worth $1.6M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Shirley A Weis (Director), with $856K. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Pediatrix Medical Group
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Funds and famous investors were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns MD
304 funds and institutions reported MD shares worth $2.3B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 16.7%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 13.71M | 16.70% | $347M | +1% |
| Vanguard Portfolio Management LLC | 5.99M | 7.29% | $152M | -3% |
| Dimensional Fund Advisors LP | 4.22M | 5.14% | $107M | +9% |
| Vanguard Capital Management LLC | 3.62M | 4.41% | $91.7M | -1% |
| State Street Corp | 3.53M | 4.30% | $89.5M | +5% |
| Victory Capital Management Inc | 3.42M | 4.16% | $86.6M | -11% |
| California State Teachers Retirement System | 3.28M | 4.00% | $130M | +3906% |
| Wasatch Advisors LP | 2.50M | 3.04% | $63.3M | +22% |
| Geode Capital Management, LLC | 2.23M | 2.71% | $56.4M | +2% |
| American Century Companies Inc | 2.19M | 2.67% | $55.5M | -44% |
| Fuller & Thaler Asset Management, Inc. | 1.72M | 2.10% | $43.6M | +40% |
| Allspring Global Investments Holdings, LLC | 1.62M | 1.97% | $42.3M | +66% |
| D. E. Shaw & Co., Inc. | 1.61M | 1.96% | $40.9M | -6% |
| Rockefeller Capital Management L.P. | 1.34M | 1.63% | $33.9M | +76% |
| Morgan Stanley | 1.33M | 1.62% | $33.7M | +6% |
| Charles Schwab Investment Management Inc | 1.29M | 1.58% | $32.8M | -10% |
| Sixth Street Partners Management Company, L.P. | 1.29M | 1.58% | $32.8M | – |
| Renaissance Technologies LLC | 1.29M | 1.57% | $32.6M | -16% |
| Lsv Asset Management | 1.19M | 1.45% | $30.2M | +107% |
| Invesco Ltd. | 1.17M | 1.43% | $29.7M | +27% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, MD insiders reported $0 of open-market purchases and $1.6M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | Shirley A Weis | Director | Sale | 36,028 | $23.75 | $856K | Form 4 |
| Dec 15, 2025 | Mark S Ordan | CEO | Sale | 23,000 | $22.41 | $515K | Form 4 |
| Nov 17, 2025 | Michael A. Rucker | Director | Sale | 10,478 | $23.00 | $241K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Shirley A Weis | Director | – | $856K | May 13, 2026 |
| Mark S Ordan | Chief Executive Officer, Director | – | $515K | Dec 15, 2025 |
| Michael A. Rucker | Director | – | $241K | Nov 17, 2025 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
MD short interest
Low short interest. 4.5% of MD shares are sold short: about 1 share in 22. Over the last 12 reports the number of shares short went up 2%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 3.55M MD shares were sold short, 4.5% of the shares outstanding, down 18.9% from the report before. At the average daily volume of 705,586 shares, buying them all back would take about 5.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 3.55M | 4.54% | -19% | 705,586 | 5.0 |
| Oct 15, 2026 | 4.37M | 5.38% | -5% | 750,346 | 5.8 |
| Sep 30, 2026 | 4.61M | 5.67% | -3% | 761,576 | 6.0 |
| Sep 15, 2026 | 4.73M | 5.82% | -2% | 685,069 | 6.9 |
| Aug 31, 2026 | 4.82M | 5.93% | -3% | 762,513 | 6.3 |
| Aug 14, 2026 | 4.94M | 6.08% | +19% | 922,389 | 5.4 |
| Jul 31, 2026 | 4.14M | 5.09% | -16% | 623,866 | 6.6 |
| Jul 15, 2026 | 4.91M | 5.98% | +29% | 905,748 | 5.4 |
| Jun 30, 2026 | 3.80M | 4.63% | +1% | 928,286 | 4.1 |
| Jun 15, 2026 | 3.76M | 4.58% | +12% | 685,438 | 5.5 |
| May 29, 2026 | 3.36M | 4.09% | -3% | 755,292 | 4.5 |
| May 15, 2026 | 3.46M | 4.22% | +2% | 1.09M | 3.2 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Pediatrix Medical Group company events
Pediatrix Medical Group filed 7 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Oct 29, 2026.
- Oct 29, 2026ResultsReleased financial results. Filing
- Aug 4, 2026ResultsReleased financial results. Filing
- Jul 24, 2026LeadershipAs previously reported, on May 1, 2026, Pediatrix Medical Group, Inc., a Florida corporation and Ms. Mary Ann E. Moore determined that Ms. Moore would transition from her role as the Executive Vice President, General Counsel, Chief Administrative Officer and Secretary of the Company prior to the… Filing
- Jul 15, 2026ResultsReleased financial results. Filing
- May 7, 2026LeadershipAs disclosed under Item 5.07 of this Current Report on Form 8-K, at the 2026 Annual Shareholders’ Meeting of Pediatrix Medical Group, Inc., a Florida corporation, held on May 7, 2026, the shareholders of the Company approved the Company’s Second Amended and Restated 2008 Incentive Compensation… Filing
- May 5, 2026ResultsReleased financial results. Filing
- Feb 19, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Pediatrix Medical Group financials
Famous investors that hold MD
4 of the 50 well-known investors we track reported holding MD in their latest 13F filing. The largest position is Jim Simons's, worth $22.4M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 871,900 | $22.4M | 0.0% | -32% |
| Israel Englander · Millennium Management | Q3 2026 | 111,057 | $2.9M | 0.0% | +101% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 57,692 | $1.5M | 0.0% | New |
| Jeremy Grantham · GMO | Q3 2026 | 7,793 | $201K | 0.0% | -29% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Pediatrix Medical Group, Inc. (MD) stock
Who owns the most MD stock?
The largest reported owner of Pediatrix Medical Group, Inc. (MD) is BlackRock, Inc., with 16.7% of the company. In total, 304 funds and institutions reported holding MD at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are MD insiders buying or selling?
In the last 12 months, MD insiders reported no open-market purchases and 3 sales worth $1.6M. The latest trade was on May 13, 2026. See every trade.
What is the short interest in MD?
As of Oct 30, 2026, 3.55M MD shares were sold short, 4.5% of the shares outstanding, down 18.9% from the report before. At the average daily volume of 705,586 shares, buying them all back would take about 5.0 trading days (days to cover). See the history.
Which famous investors hold MD?
4 of the 50 well-known investors we track reported MD in their latest 13F filing, including Jim Simons, Israel Englander, Ken Griffin. The largest position is worth $22.4M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.